A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients
Authors
Keywords
Ovarian cancer, Tumor-associated macrophage, M1, M2, Prognosis
Journal
Journal of Ovarian Research
Volume 7, Issue 1, Pages 19
Publisher
Springer Nature
Online
2014-02-09
DOI
10.1186/1757-2215-7-19
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correlations of Tumor-associated Macrophage Subtypes with Liver Metastases of Colorectal Cancer
- (2013) Yun-Long Cui et al. Asian Pacific Journal of Cancer Prevention
- Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
- (2013) Y Ino et al. BRITISH JOURNAL OF CANCER
- Myeloid Cell Receptor LRP1/CD91 Regulates Monocyte Recruitment and Angiogenesis in Tumors
- (2013) Nicole D. Staudt et al. CANCER RESEARCH
- Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma
- (2013) Manabu Shigeoka et al. CANCER SCIENCE
- Therapeutic gene modified cell based cancer vaccines
- (2013) Anna Kozłowska et al. GENE
- Calreticulin expression is reduced in high-grade ovarian serous carcinoma effusions compared with primary tumors and solid metastases
- (2013) Olga Vaksman et al. HUMAN PATHOLOGY
- Infiltration of Tumor-associated Macrophages is Increased in the Epithelial and Stromal Compartments of Endometrial Carcinomas
- (2013) Erica C. Dun et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Increased Understanding of the Biochemistry and Biosynthesis of MUC2 and Other Gel-Forming Mucins Through the Recombinant Expression of Their Protein Domains
- (2013) Malin Bäckström et al. MOLECULAR BIOTECHNOLOGY
- Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche
- (2013) Andrea Flesken-Nikitin et al. NATURE
- Induction of M2-macrophages by tumour cells and tumour growth promotion by M2-macrophages: A quid pro quo in pancreatic cancer
- (2013) L.I. Partecke et al. PANCREATOLOGY
- Immunohistochemical Analysis of Inflammatory Cells in Benign and Precancerous Lesions and Carcinoma of the Prostate
- (2013) Tomomi Fujii et al. PATHOBIOLOGY
- Precursors and pathogenesis of ovarian carcinoma
- (2013) D. Lim et al. PATHOLOGY
- The Clinical Significance of the CD163+ and CD68+ Macrophages in Patients with Hepatocellular Carcinoma
- (2013) Ling-Qun Kong et al. PLoS One
- Prognostic Value of Tumor-associated Macrophages Count in Human Non-muscle-invasive Bladder Cancer Treated by BCG Immunotherapy
- (2013) Faouzia Ajili et al. ULTRASTRUCTURAL PATHOLOGY
- Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse model
- (2013) Andrew J Wilson et al. Journal of Ovarian Research
- Roles of the Gel-Forming MUC2 Mucin and Its O-Glycosylation in the Protection against Colitis and Colorectal Cancer
- (2012) Hiroto Kawashima BIOLOGICAL & PHARMACEUTICAL BULLETIN
- The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients
- (2012) Catharina Medrek et al. BMC CANCER
- Importance of direct macrophage - Tumor cell interaction on progression of human glioma
- (2012) Yoshihiro Komohara et al. CANCER SCIENCE
- Surgical Management of Epithelial Ovarian Cancer
- (2012) RITU SALANI et al. CLINICAL OBSTETRICS AND GYNECOLOGY
- IL10, IL11, IL18 are differently expressed in CD14+ TAMs and play different role in regulating the invasion of gastric cancer cells under hypoxia
- (2012) Zhanlong Shen et al. CYTOKINE
- Protein Expression Changes in Ovarian Cancer during the Transition from Benign to Malignant
- (2012) Sofia Waldemarson et al. JOURNAL OF PROTEOME RESEARCH
- Tumor-associated macrophages and the profile of inflammatory cytokines in oral squamous cell carcinoma
- (2012) Nadia Lago Costa et al. ORAL ONCOLOGY
- The Distribution of Macrophages with a M1 or M2 Phenotype in Relation to Prognosis and the Molecular Characteristics of Colorectal Cancer
- (2012) Sofia Edin et al. PLoS One
- Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
- (2012) Qiong-wen Zhang et al. PLoS One
- Density of Tumor-Associated Macrophages Correlates with Lymph Node Metastasis in Papillary Thyroid Carcinoma
- (2012) Wei Qing et al. THYROID
- Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
- (2012) Jaime Prat VIRCHOWS ARCHIV
- Ovarian Cancer Management: The role of imaging and diagnostic challenges
- (2011) Nishat Bharwani et al. EUROPEAN JOURNAL OF RADIOLOGY
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
- (2011) Robert J. Kurman et al. HUMAN PATHOLOGY
- Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis
- (2011) W. Glenn McCluggage PATHOLOGY
- Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers
- (2011) Michael P. Stany et al. PLoS One
- Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma
- (2011) Mona A. A. Zaki et al. VIRCHOWS ARCHIV
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
- (2010) Robert J. Kurman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time
- (2010) Junliang Ma et al. BMC CANCER
- Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma
- (2010) Horlad Hasita et al. CANCER SCIENCE
- Intratumoral Mediated Immunosuppression is Prognostic in Genetically Engineered Murine Models of Glioma and Correlates to Immunotherapeutic Responses
- (2010) L.-Y. Kong et al. CLINICAL CANCER RESEARCH
- Multiple Roles of Chemokine (C-C Motif) Ligand 2 in Promoting Prostate Cancer Growth
- (2010) J. Zhang et al. JNCI-Journal of the National Cancer Institute
- Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms
- (2010) Laura J Tafe et al. MODERN PATHOLOGY
- Selection of Endometrial Carcinomas for DNA Mismatch Repair Protein Immunohistochemistry Using Patient Age and Tumor Morphology Enhances Detection of Mismatch Repair Abnormalities
- (2009) Karuna Garg et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- CA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers
- (2009) Chunqiao Tian et al. CANCER
- Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival
- (2009) C. M. Ohri et al. EUROPEAN RESPIRATORY JOURNAL
- p53 autoantibodies, cytokine levels and ovarian carcinogenesis
- (2009) Miyun Tsai-Turton et al. GYNECOLOGIC ONCOLOGY
- Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation
- (2009) Alberto Mantovani et al. HUMAN IMMUNOLOGY
- The expression of HMGB1 protein and its receptor RAGE in human malignant tumors
- (2009) Nora Kostova et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Profound but Dysfunctional Lymphangiogenesis via Vascular Endothelial Growth Factor Ligands from CD11b+ Macrophages in Advanced Ovarian Cancer
- (2008) B.-H. Jeon et al. CANCER RESEARCH
- The immunogenicity of tumor cell death
- (2008) Oliver Kepp et al. CURRENT OPINION IN ONCOLOGY
- Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer
- (2008) Ajay P Singh et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More